Association between circadian gene CLOCK and cisplatin resistance in ovarian cancer cells: A preliminary study.

about

Association between circadian gene CLOCK and cisplatin resistance in ovarian cancer cells: A preliminary study.

Item

http://www.wikidata.org/entity/Q55044842

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Association between circadian ...... er cells: A preliminary study.

@en

Association between circadian ...... er cells: A preliminary study.

@nl

type

Item

label

Association between circadian ...... er cells: A preliminary study.

@en

Association between circadian ...... er cells: A preliminary study.

@nl

prefLabel

Association between circadian ...... er cells: A preliminary study.

@en

Association between circadian ...... er cells: A preliminary study.

@nl

P1476

Association between circadian ...... er cells: A preliminary study.

@en

P2093

Guoyan Mo

http://www.w3.org/2001/XMLSchema#string

Hai Xu

http://www.w3.org/2001/XMLSchema#string

Hao Chen

http://www.w3.org/2001/XMLSchema#string

Zhiyin Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Cancer statistics, 2013

Targeted immune therapy of ovarian cancer

Integrative network analysis of TCGA data for ovarian cancer.

Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer

Deregulated expression of circadian clock genes in gastric cancer.

β-arrestin 2 is associated with multidrug resistance in breast cancer cells through regulating MDR1 gene expression

High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma.

Association between alcohol consumption and the risk of ovarian cancer: a meta-analysis of prospective observational studies.

MCT1 promotes the cisplatin-resistance by antagonizing Fas in epithelial ovarian cancer.

P304

8945-8950

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.8488

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29844814

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

circadian rhythm

P932

5958788

http://www.w3.org/2001/XMLSchema#string